Oculis Holding AG (OCS)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-12-01 | Phase3 Readout | — |
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07548632 | A Clinical Study Evaluating Licaminlimab for Dry Eye Disease | PHASE3 | Recruiting | 160 |
| NCT07623668 | Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research | PHASE3 | Recruiting | 210 |
| NCT05608837 | Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema | PHASE2 | Active Not Recruiting | 28 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.